BPIQ Blog

$XBI $118.22 +1.46%% Covid Updates $PFE -1.4% & $BNTX -1.7% Pfizer and BioNTech Submit Updated Longer-Term Follow-Up Data of COMIRNATY®...

$XBI $116.52 -0.1%% Covid Updates $GILD +0.8% Gilead Announces New England Journal of Medicine Publication of Data Demonstrating...

$XBI $116.58 +0.68%% Covid Updates $NVAX -5.4% Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study...

$XBI $115.79 +0.16%% Covid Updates $NVAX -7.1% World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19...

$XBI $115.61 +4.78%% Covid Updates $GSK Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early...

$XBI $110.34 -2.7%% Covid Updates $AXLA +0.4% Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial...

$XBI $113.39 +4.25%% Covid Updates $CDXS +2.4% Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in...

$XBI $108.77 -1.83%% Covid Updates $ORMP -6.8% Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19...

$XBI $110.80 +0.81%% Covid Updates $ Pipeline Updates $SRRA -2.0% Sierra Oncology Reports Baseline Ferritin Differentially Predicts Week...

$XBI $109.91 -1.67% Covid Updates $MRNA Moderna Announces Additional 20 Million Doses of COVID-19 Vaccine to COVAX for Supply in 2021...

$XBI $111.78 -4.2% Covid Updates $BNTX -2.7% & $PFE +1.4% Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19...

$XBI $116.69 +1.43% Covid Updates $AZN +0.7% Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use...

$XBI $115.04 +5.0%% Covid Updates $ Pipeline Updates $LEGN +9.8% Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from...

$XBI 109.58 +0.05% Covid Updates $RDHL +3.9% RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein...

$XBI | $109.53 | -4.40% Covid Updates $ABCL AbCellera-Discovered Bamlanivimab Together with Etesevimab Authorized as the First and Only...

$XBI $114.57 +2.18% Covid Updates $VALN +0.62% Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its...

$XBI $112.13 -3.56% Covid Updates $IMNM -5.9% Immunome Expects IMM-BCP-01 Antibody Cocktail to Neutralize the SARS-CoV-2 Omicron...

$XBI $116.27 +1.06% Pipeline Updates $SRRK +4.1% Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab...

$XBI $115.05 +1.5% Covid Updates $GRTS -5.6% The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets)...

$XBI $120.05 +0.56% Covid Updates $NVAX -0.3% Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore. source Pipeline...